Antimicrobial Resistance The “Scariest” Public Health Issue, Needs Financial R&D Incentives, Industry Says

Publication

Intellectual Property Watch

By

Catherine Saez

On the eve of the annual January World Health Organization Executive Board meeting, an alliance of pharmaceutical industries launched its first report on efforts made to curb antimicrobial resistance. The alliance also organised a conference on the report and on challenges of antimicrobial resistance, in particular the need for research and development incentives so that the industry can continue its efforts sustainably. Some light was also shed on the need to support access to diagnostics, and lower their prices.

More News

News

A Decade of Action on AMR: Reflections and Path to 2029

In the news

WAAW Webinar 2025

News

AMR Industry Alliance Releases “Principles for Pooled Procurement of AMR Products”